EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis

Xinlei Cai iD, Yi Ye, Xiaoping Liu iD, Zhaoyuan Fang, Luonan Chen, Fei Li, Hongbin Ji iD

eLife · 2025

DOI: 10.7554/elife.101619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Xinlei Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese A…. Hauptthemen laut MEDLINE: Mitosis, Neoplasms, Lung Neoplasms. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inconsistency of the association between genes and cancer prognosis is often attributed to many variables that contribute to patient survival. Whether there exist the G enes St e adily A ssociated with P r ognosis (GEARs) and functions remains largely elusive. Here, we developed a novel method named ‘ M ulti-gradi e nt Per m utati o n Su r vival Anal y sis’ (MEMORY) to screen the GEARs by using RNA-seq data from the TCGA database. We employed a network construction approach to identify hub genes from GEARs and utilized them for cancer classification. In the case of lung adenocarcinoma (LUAD), the GEARs were found to be related to mitosis. Our analysis suggested that LUAD cell lines carrying PIK3CA mutations exhibit increased drug resistance. For breast invasive carcinoma (BRCA), the GEARs were related to immunity. Further analysis revealed that CDH1 mutation might regulate immune infiltration through the EMT process. Moreover, we explored the prognostic relevance of mitosis and immunity through their respective scores and demonstrated it as valuable biomarkers for predicting patient prognosis. In summary, our study offered significant biological insights into GEARs and highlights their potentials as robust prognostic indicators across diverse cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitosisNeoplasmsLung NeoplasmsHumansPrognosisSurvival AnalysisBiomarkers, TumorBreast NeoplasmsMutationCell Line, TumorAdenocarcinoma of LungGene Expression Regulation, NeoplasticClass I Phosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

GEARGene Steadily Associated with PrognosisMEMORYMulti-gradient Permutation Survival Analysiscancer biologyhub geneshumanimmunemitosis

Substanzen

Biomarkers, TumorClass I Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
  • State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Haining, China.
  • The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Department of Pathology and Frontier Innovation Center, School of Basic Medical Sciences, Fudan University, Shanghai, China.

ORCID-Profile: Xinlei Cai, Xiaoping Liu, Hongbin Ji

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Innovative research team of high-level local universities in Shanghai

Zitieren

APA

Cai, X., Ye, Y., Liu, X., Fang, Z., Chen, L., Li, F., & Ji, H. (2025). Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis. eLife. https://doi.org/10.7554/elife.101619

Vancouver

Cai X, Ye Y, Liu X, Fang Z, Chen L, Li F, et al. Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis. eLife. 2025. doi:10.7554/elife.101619

BibTeX
@article{Cai2025,
  author = {Cai, Xinlei and Ye, Yi and Liu, Xiaoping and Fang, Zhaoyuan and Chen, Luonan and Li, Fei and Ji, Hongbin},
  title = {Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.101619}
}
Kostenlos starten →